Fatma Levent, MD

Fatma Levent, MD

Pediatric Infectious Diseases Specialist

Pediatrics

Overview

Fatma Levent, MD, is a board-certified pediatric infectious diseases specialist. She was an assistant professor at the Texas Tech Health Sciences Center where she lectured on a wide range of infectious disease topics. Dr. Levent holds certifications from the American Board of Pediatrics including xSub-Board of Pediatric Infectious Diseases and is a member of the Pediatric Infectious Diseases Society and the Society of Healthcare Epidemiology of America.

Articles

Uncommon aetiology of lymphadenopathy in a healthy child: a sporotrichosis case with painless lymphadenopathy

BMJ case reports

2022

Atrioventricular Conduction Abnormalities in Multisystem Inflammatory Syndrome in Children

CASE REPORTS IN PEDIATRICS

2021

Screening Awareness of HPV-Related Oropharyngeal Cancers and Attitudes and Concerns towards HPV Vaccination Among Parents HPV and Oropharyngeal Cancer

JOURNAL OF CANCER EDUCATION

2021

Burkholderia cepacia Sepsis in a Previously Healthy Full-Term Infant

CASE REPORTS IN PEDIATRICS

2020

CASE OF A PEDIATRIC SPINAL DORSAL DERMAL SINUS TRACT WITH SPINAL ABSCESS AND RECURRENT MENINGITIS

JOURNAL OF INVESTIGATIVE MEDICINE

2020

AN UNCOMMON ETIOLOGY OF SEPTIC SHOCK IN A TERM INFANT

JOURNAL OF INVESTIGATIVE MEDICINE

2020

NOT JUST ANOTHER VIRUS: LEUKOPENIA AND TRANSAMINITIS IN AN 18-MONTH-OLD MALE

JOURNAL OF INVESTIGATIVE MEDICINE

2020

CHRONIC GRANULOMATOUS HSV ENCEPHALITIS IN A PRESCHOOL CHILD

JOURNAL OF INVESTIGATIVE MEDICINE

2020

HYBRIDIZED PEDAGOGY: A NOVEL APPROACH TO TEAACHING GLOBAL HEALTH AND TROPICAL MEDICINE

JOURNAL OF INVESTIGATIVE MEDICINE

2020

How to Treat Cytomegalovirus-induced Hemophagocytic Lymphohistiocytosis in a Child With Leukemia

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

2020

More Publication Information

Education & Training

Education

Cukurova University, Faculty of Medicine, Adana, Turkey

Residency

Texas Tech University Health Sciences Center, Lubbock, TX

Fellowship

Pediatric Infectious Diseases at Baylor College of Medicine, Houston, TX

Board Certifications

American Board of Pediatrics

Associated Clinical Trials

NCT04223752

A Phase 1, open-label, non-comparative, multicenter clinical study to evaluate the safety, tolerability, and pharmacokinetics of ceftolozane/tazobactam (MK-7625A) in pediatric participants with nosocomial pneumonia

Ceftolozane/tazobactam, also known as Zerbaxa, is a combination product, and is available by prescription for use in adults for the treatment of complicated urinary tract infections, including pyelonephritis (serious infection ...